In Re Blood Reagents Antitrust Litigation
District Court, E.D. Pennsylvania
1Opinion of the Court
MEMORANDUM
DuBOIS, District Judge.
I. INTRODUCTION
In these consolidated antitrust actions, plaintiffs allege that the two leading pro ducers of blood reagents — Immucor, Inc. (“Immucor”) and Ortho Clinical Diagnostics, Inc. (“Ortho Clinical”) — conspired to unreasonably restrain trade and commerce in violation of § 1 of the Sherman Antitrust Act, 15 U.S.C. § 1. By Order of August 23, 2010, the Court denied the motions to dismiss filed by Immucor and Ortho Clinical. 1 The defendants then timely filed a Motion for Reconsideration or for Certification of an Interlocutory Appeal, which is presently…
2Cases cited15 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Coopers & Lybrand v. LivesaySupreme Court of the United States · 1978
- Alston v. ParkerCourt of Appeals for the Third Circuit · 2004
- In Re Insurance Brokerage Antitrust LitigationCourt of Appeals for the Third Circuit · 2010
10 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Jarzyna v. Home Properties, L.P.District Court, E.D. Pennsylvania · 2016
- In re Blood Reagents Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2012
- Williams v. Standard Fire InsuranceDistrict Court, M.D. Pennsylvania · 2012
- DOWNS v. BOROUGH OF JENKINTOWNDistrict Court, E.D. Pennsylvania · 2020
- FEDERAL TRADE COMMISSION v. AMERICAN FUTURE SYSTEMS, INC.District Court, E.D. Pennsylvania · 2024
12 more not listed; retrieve them via the Exa API.